期刊文献+

冠心病人群血清NO、ET、hs-CRP、TNF-α和脂联素水平的相互关系 被引量:8

Relationship Among NO,ET,hs-CRP,TNF-α and Adiponectin Levels in Coronary Heart Disease
暂未订购
导出
摘要 为探讨冠心病人群中血清一氧化氮(NO)、内皮素(ET)、高敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)、脂联素和胆固醇(TC)水平并分析其相互之间的关系,本文选定对照组(A组)20名、单纯冠心病组(B组)32例和冠心病伴高胆固醇血症组(C组)36例,对上述指标进行检测。结果表明:ET:B组(66.5±48.3pg/mL)、C组(73.2±53.8pg/mL)与A组(50.1±20.7pg/mL)比,分别P<0.01和P<0.001;hs-CRP:B组(2.18±2.02mg/dL)、C组(3.08±2.73mg/dL)与A组(1.46±1.26mg/dL)比,P均小于0.001;TNF-:αB组(19.0±7.0pg/mL)、C组(25.0±9.0pg/mL)与A组(15.0±5.0pg/mL)比,P均小于0.001;NO:B组(43.5±22.7μmol/L)、C组(40.1±20.3μmol/L)与A组(75.4±40.6μmol/L)比,P均小于0.001;脂联素:B组(8.58±2.72mg/L)、C组(7.08±2.03mg/L)与A组(12.46±3.26mg/L)比,P均小于0.001。血清脂联素水平和冠状动脉狭窄程度呈负相关(P<0.01)。在以TC为应变量的多元回归分析中,hs-CRP、脂联素进入方程(P<0.001)。冠心病人群的血清ET、hs-CRP、TNF-α水平显著高于非冠心病人群,血清NO、脂联素水平则与之相反。脂联素和TC、hs-CRP同样是一个很好的评价冠心病冠状动脉粥样硬化严重程度的指标。 To measure NO, ET, hs-CRP , TNF-α and adiponectin levels and to analyse relationships among them in 68 patients with coronary heart disease(CHD) and 20 control subjects (group A), the coronary heart disease subjects according to their blood total cholesterol(TC) level were divided into simple CHD group (B, n=32) and CHD with hypercholesterolemia group (C, n= 36). Fasting TC, NO, ET, hs-CRP, TNF-α and adiponectin concentrations were measured in all subjects. The relationships among these factors were analyzed . The ser um ET, hs-CRP, TNF-α levels in group B were significantly higher than those in group A, while serum NO and adiponectin levels were significantly lower in group B than those in group A. Adiponectin level was significantly correlated with coronary artery stenosis degree. TC, hs- CRP and adiponectin levels are good indexes in evaluating the CHD.
出处 《标记免疫分析与临床》 CAS 2006年第1期4-6,3,共4页 Labeled Immunoassays and Clinical Medicine
基金 无锡市卫生局课题基金(NO.2004-00115)
关键词 冠心病 胆固醇 一氧化氮 内皮素 高敏C反应蛋白 肿瘤坏死因子口 脂联素 Coronary heart disease Blood total cholesterol Nitricoxide Endothelin Turmor necrosis factor High-sensitive C reactive protein Adiponectin
  • 相关文献

参考文献13

  • 1Takahashi M,Arita Y,Yamagata K,et al.Genomic structure and mutations in adipose-specific gene,adiponectin[J].Int J Obse,2000,24:861-868.
  • 2Ouchi N,Kihara S,Arita Y,et al.Adiponectin,an adipocytederived plasma protein,inhibits NF-Kb signaling through a cAMP-dependent pathway[J].Circulation,2000,102:1296-1301.
  • 3陶军,涂昌,王妍,杨震,刘东红,徐明国,王浩梅,张焰,曾群英,陈国伟.冠心病患者血管内皮功能障碍与动脉弹性关系的研究[J].中华心血管病杂志,2005,33(2):150-152. 被引量:42
  • 4冯宗忱.动脉粥样硬化——血管壁的慢性炎症[J].中华心血管病杂志,2005,33(5):393-394. 被引量:66
  • 5石文蕾,张煜,张维,宫玲,王慧婷,朱毅,郑柏生,殷民德.超敏C反应蛋白与老年冠心病严重程度的关系[J].国外医学(心血管疾病分册),2005,32(3):182-184. 被引量:17
  • 6Hotta K,Funahashi T,Arita Y,et al.Plasma concentration of a novel,adipose-specific protein,adiponectin,in type 2 diabetic patients[J].Arterioscler Thromb Vasc Biol,2000,20:1595-1599.
  • 7Kondo H,Shimomura I,Matsukawa Y,et al.Association of adiponectin mutation with type 2 diabetes.A candidate gene for the insulin resistance syndrome[J].Diabetes,2002,51:2325-2328.
  • 8Motoshima H,Wu X,Mahadev K,et al.Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL[J].Biochem Biophys Res Commun,2004,315(2):264-271.
  • 9Kumada M,Kihara S,Ouchi N,et al.Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages[J].Circulation,2004,109 (17):2046-2049.
  • 10Yamamoto Y,Hirose H,Saito I,et al.Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol,independent of body mass index,in the Japanese population[J].Clin Sci (Lond),2002,103:137-142.

二级参考文献60

  • 1刘军,陈影,刘芳,姚庆姑,许火根,澎名淑,郭瑜琳,陈钦达.2型糖尿病家系非糖尿病一级亲属脂联素水平与胰岛素抵抗和动脉粥样硬化相关性研究[J].中华内分泌代谢杂志,2004,20(3):215-216. 被引量:30
  • 2Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res, 2000,32:47-50.
  • 3Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation, 2000,102:1296-1301.
  • 4Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 2000,96:1723-1732.
  • 5Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem, 2002,277:37487-37491.
  • 6Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 2002,277:25863-25866.
  • 7Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun, 1999,257:79-83.
  • 8Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000,20:1595-1599.
  • 9Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadi-ponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003,23:85-89.
  • 10Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51:606.

共引文献236

同被引文献54

引证文献8

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部